Clinical Trial Update: Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update on intranasal sufentanil, ketamine, and CT001 for pain, reporting efficacy and PK-PD relationships.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• CT001
• Ketamine (ketamine)
• Sufentanil (sufentanil)

Snippet

Sponsor: Cessatech A/S | Conditions: Pain | Phase 2, Phase 3 | Status: COMPLETED